- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AJMC® in the Press, February 9, 2024
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Articles in Medriva and Becker’s Payer Issues referenced a study published in the February 2024 issue of The American Journal of Managed Care® (AJMC®). The study, “Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans,” found that calling patients at the time of enrollment in a health plan could help in collecting health literacy data.
A piece by PharmExec referenced an article published by AJMC’s sister site, The Center for Biosimilars®. The article, “Why Pharmacovigilance Is Important for Biosimilars,” emphasized the need for constant pharmacovigilance among clinicians due to how many factors can affect the quality and performance of biosimilars.
Hope on the Horizon for Underserved Patients With Multiple Myeloma: Joseph Mikhael, MD
August 12th 2025Explore the disparities in multiple myeloma treatment and how new initiatives aim to improve clinical trial participation among underrepresented patients during a conversation with Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO, chief medical officer of the International Myeloma Foundation.
Listen
What It Takes to Improve Guideline-Based Heart Failure Care With Ty J. Gluckman, MD
August 5th 2025Explore innovative strategies to enhance heart failure treatment through guideline-directed medical therapy, remote monitoring, and artificial intelligence–driven solutions for better patient outcomes.
Listen
In Study Across 15 Centers, 35% of Patients With MCL See Progression After CAR T-Cell Therapy
August 15th 2025Study reveals one-third of mantle cell lymphoma patients in a study at leading cancer centers experienced disease progression after CAR T-cell therapy, highlighting treatment challenges and outcomes.
Read More
